MktsMarkets

Indivior Pharmaceuticals, Inc.
NASDAQ: INDVKey statistics
INDV News
Stories mentioning INDV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 317,000 | 357,000 | 314,000 | 302,000 | 266,000 | 307,000 | 299,000 | |
| Cost of Goods Sold | 40,000 | 67,000 | 83,000 | 52,000 | 44,000 | 66,000 | 79,000 | |
| Gross Profit | 277,000 | 293,000 | 230,000 | 250,000 | 221,000 | 0.00 | 241,000 | 220,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 124,000 | 188,000 | 155,000 | 158,000 | 133,000 | 175,000 | 142,000 | 152,000 |
| Total Operating Expenses | 139,000 | 187,000 | 156,000 | 205,000 | 206,000 | 338,000 | ||
| Operating Income (Loss) | 137,000 | 81,000 | 43,000 | 72,000 | 66,000 | 46,000 | 35,000 | (118,000) |
| Interest Income | 3,000 | 6,000 | 6,000 | 6,000 | 4,000 | 5,000 | 5,000 | 6,000 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 115,000 | 81,000 | 37,000 | 62,000 | 59,000 | 38,000 | 30,000 | (121,000) |
| Tax Provision | 26,000 | (21,000) | (5,000) | 44,000 | 11,000 | 17,000 | 8,000 | (23,000) |
| Net Income (Loss) | 89,000 | 103,000 | 42,000 | 18,000 | 47,000 | 21,000 | 22,000 | (97,000) |
| Earnings Per Share (Basic) | 0.71 | 0.82 | 0.34 | 0.15 | 0.38 | 0.16 | 0.16 | (0.72) |
| Earnings Per Share (Diluted) | 0.69 | 0.80 | 0.33 | 0.14 | 0.38 | 0.16 | 0.16 | (0.72) |
| Weighted Average Shares Outstanding (Basic) | 124,000 | 125,000 | 125,000 | 125,000 | 124,000 | 132,000 | 132,000 | 135,000 |
| Weighted Average Shares Outstanding (Diluted) | 129,000 | 128,000 | 129,000 | 126,000 | 125,000 | 133,000 | 133,000 | 135,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About INDV
Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) is a stock listed on the Nasdaq Stock Market under the ticker symbol INDV. It last traded at $27.62 (Nov 8, 2026, 7:00 PM ET), up 5.6% on the day. That gives Indivior Pharmaceuticals a market capitalisation of $4.3B and a price-to-earnings ratio of 12.1.
Over the past 52 weeks INDV has traded between $25.92 and $42.81.
Revenue for the quarter ended Mar 31, 2026 was $317.0M; net income $89.0M. Revenue was up 19.2% from $266.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $317.0M | $89.0M | 28.1% |
| Dec 31, 2025 | $357.0M | $103.0M | 28.9% |
| Sep 30, 2025 | $314.0M | $42.0M | 13.4% |
| Jun 30, 2025 | $302.0M | $18.0M | 6.0% |
From Indivior Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…